What is the EVMN stock price prediction for next 2 weeks?

According to our price prediction algorithm,Evommune, Inc. (EVMN) price will be around $20.76 in the next 2 weeks. This means it will decrease by -8.505949757602465 from the last closing price. This prediction may vary from other time period filters for EVMN stock.

What can be the highest Possible price of EVMN stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, EVMN can achieve the highest price of $22.27 which is -1.831196676822872 lower than last closing price. This prediction may vary from other time period filters for EVMN stock.

What can be the lowest Possible price of EVMN stock in next 2 weeks?

As per the forecast and algorithmic analysis, EVMN stock price can be as low as $19.15 which is -15.60522414330313 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for EVMN stock.

Will EVMN stock go high in the next 2 weeks?

No, our stock forecasting algorithm shows that EVMN stock will lose-8.505949757602465 in the next 2 weeks. This prediction may vary from other time period filters for EVMN stock.

What is EVMN stock last closing price?

Last closing price of EVMN stock was $22.69.

What is EVMN stock price prediction?

EVMN stock price prediction means predicting the future closing prices of EVMN stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of EVMN stock in a certain time period.

How we predict EVMN stock future prices?

If you are searching for EVMN stock forecast, analysis or price prediction, then you might be wondering what Evommune, Inc. (EVMN) will do in the future. Our EVMN price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This EVMN price prediction will likely answer most of your questions.

How frequent we update EVMN stock predictions?

We are updating the forecasts for the EVMN stock on daily basis.

Is using ML forecasting for EVMN stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for EVMN stock same for all the time periods?

No, the prediction for EVMN stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Evommune, Inc. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$22.69-4.86%Since 2 Weeks

Predicted Price$20.76-8.51%For 2 Weeks

Upper Predicted Price$22.27-1.83%For 2 Weeks

Lower Predicted Price$19.15-15.61%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of EVMN will decline by -8.51% over the next 2 Weeks and hit $20.76 by Tuesday, May 26, 2026. In that time frame, EVMN's share price is expected to range between $19.15 and $22.27.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
May 26, 2026	19.15	20.76	22.27
May 25, 2026	19.50	21.02	22.71
May 22, 2026	19.78	21.32	22.92
May 21, 2026	20.27	21.85	23.34
May 20, 2026	20.52	21.98	23.42
May 19, 2026	20.31	21.79	23.28
May 18, 2026	20.64	22.05	23.42
May 15, 2026	20.80	22.36	23.83
May 14, 2026	21.39	22.89	24.39
May 13, 2026	21.46	23.01	24.50

EVMN shares rose +1.15% in Wednesday, May 13, 2026's trading session, rising from a previous close of $22.69 to move at $22.95. The stock demonstrated notable intraday movement (see EVMN's key stats for a full breakdown), fluctuating between $22.26 and $23.09, a +3.75% trading range. While recent weeks have seen some volatility, EVMN has managed to secure a -10.28% drop over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 279.17K shares changing hands, 387.95K fewer than the previous session. This amounted to $6.41M in total market activity.

Will EVMN Continue Its Downward Trend?

According to analyst ratings and projections for EVMN, Evommune, Inc. shares are anticipated to decrease by -3.03%, potentially reaching $22.27 per share by May 26, 2026. Short-term technical indicators currently suggest a neutral sentiment for EVMN. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 16 positive trading days within the past 30 sessions. Based on the EVMN stock forecast, now is not the best time to buy EVMN stock because its current trading price is +10.55% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on EVMN covering social and institutional perspectives.

EVMN Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into EVMN's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 39.77% to 45.37%) suggest mixed signals, with the stock in a neutral to slightly bearish momentum phase. The 50-day RSI, at 49.33%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 50.75%, maintains a neutral outlook for the long term. Insights into EVMN's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Evommune Short-Term Forecasts

EVMN Forecast For Next 5 Days

Our algorithm anticipates Evommune (EVMN) stock could hit $24.93 by May 20, 2026. This represents a +8.62% fall from today's price, following a -12.96% change over the past five days.

EVMN Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Evommune, Inc. (EVMN) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $21.95, which would mean a -4.36% decrease from the current price of $22.95. Projections for this period range from a high of $28.04 to a low of $14.42.

EVMN Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Evommune's price over the next three months point to a rise. EVMN stock is expected to peak at $37.61 on Jul 16, 2026 after potentially dipping to $20.78 on Jun 03, 2026. On average, EVMN is likely to trade around $26.85 in the coming 90 days.

Evommune Stock Forecast 2025

Based on our predictive models, Evommune (EVMN) is expected to trade between $20.78 and $43.26 throughout 2026. This would result in an average price of $29.59, potentially offering investors a +28.93% return from current levels.

Evommune, Inc. Monthly Forecast 2026–2027

May 2026

According to our latest forecast models, Evommune, Inc. (EVMN) is positioned to show a strong performance in May 2026. The price is predicted to move between $21.52 and $24.09, settling at an average of $22.70. This could translate to a -1.09% loss.

June 2026

Based on current market signals, Evommune, Inc. is projected to trend june 2026. We forecast a trading range from $20.78 to $26.33, with a likely average price of $24.00. Investors could expect a potential return of +4.58%.

July 2026

Our predictive algorithms indicate Evommune, Inc. stock may see a shift in July 2026. The expected range spans $22.38–$37.61, with an average target of $30.99. This represents a positive outlook and a possible gain of +35.03%.

August 2026

Analyzing established trends, Evommune, Inc. looks set to move in August 2026. Projections place the stock between $26.68 and $30.86, averaging around $28.62. This suggests a +24.71% gain from current levels.

September 2026

Market indicators suggest Evommune, Inc. could experience notable changes during September 2026. Prices could fluctuate within $29.22 to $32.04, with a midpoint forecast of $30.99. The stock might deliver a +35.03% gain.

October 2026

Forecasting for October 2026, models estimate that Evommune, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $26.65 and $31.01, averaging $28.67. This signals a positive trajectory with potential returns around +24.92%.

November 2026

According to our latest forecast models, Evommune, Inc. (EVMN) is positioned to show a strong performance in November 2026. The price is predicted to move between $27.46 and $32.16, settling at an average of $30.19. This could translate to a +31.55% gain.

December 2026

Based on current market signals, Evommune, Inc. is projected to trend december 2026. We forecast a trading range from $28.08 to $43.26, with a likely average price of $37.34. Investors could expect a potential return of +62.70%.

January 2027

Our predictive algorithms indicate Evommune, Inc. stock may see a shift in January 2027. The expected range spans $32.53–$36.08, with an average target of $34.43. This represents a positive outlook and a possible gain of +50.02%.

February 2027

Analyzing established trends, Evommune, Inc. looks set to move in February 2027. Projections place the stock between $35.94 and $37.94, averaging around $36.98. This suggests a +61.13% gain from current levels.

March 2027

Market indicators suggest Evommune, Inc. could experience notable changes during March 2027. Prices could fluctuate within $32.41 to $36.63, with a midpoint forecast of $34.51. The stock might deliver a +50.37% gain.

April 2027

Forecasting for April 2027, models estimate that Evommune, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $33.35 and $38.03, averaging $36.00. This signals a positive trajectory with potential returns around +56.86%.

May 2027

According to our latest forecast models, Evommune, Inc. (EVMN) is positioned to show a strong performance in May 2027. The price is predicted to move between $36.14 and $49.37, settling at an average of $43.22. This could translate to a +88.32% gain.

EVMN's history of dividends and stock splits also plays a role in long-term investor confidence.